| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 04/06/1994 | EP0589930A1 GABA-A RECEPTOR SUBUNITS ($g(a)-2, $g(a)-3, $g(a)-5, $g(a)-6, $g(b)-2) AND TRANSFECTED CELLS EXPRESSING THEM |
| 04/06/1994 | EP0489116B1 Fusion proteins comprising gm-csf and il-3 |
| 04/06/1994 | EP0418297B1 Pharmaceutical compositions and use thereof in treating inflammation |
| 04/06/1994 | EP0383856B1 Use of peptides for inhibiting blood vessel blockage |
| 04/06/1994 | CN1084855A PFEMP3 malaria antigen, analogs, antibodies and uses thereof |
| 04/06/1994 | CN1084849A Dual action inhibitors |
| 04/06/1994 | CN1084742A Pharmaceutical and/or cosmetic composition and the use thereof |
| 04/06/1994 | CN1084716A Food preservative and production thereof |
| 04/06/1994 | CA2107598A1 Ointment for treatment of epithelial lesions |
| 04/05/1994 | US5300632 Method for purifying an outer membrane protein of Haemophilus influenzae |
| 04/05/1994 | US5300629 Bactericidal and/or bacteriostatic peptides isolated from hemolymph of honeybees |
| 04/05/1994 | US5300501 Metalloproteinase inhibitors |
| 04/05/1994 | US5300492 Suppressing levels of sex hormones in male or female mammals |
| 04/05/1994 | US5300491 Administering a divalent metal salt of bacitracins as antiprotozoa agents |
| 04/05/1994 | US5300490 Anticoagulant substance obtained from urine |
| 04/05/1994 | US5300433 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 04/05/1994 | US5300292 Adminstering interleukin-6 and transforming growth factor-beta mixture |
| 04/05/1994 | CA1328333C Amino acid derivatives |
| 04/05/1994 | CA1328332C Peptide boronic acid inhibitors of trypsin-like proteases |
| 04/05/1994 | CA1328188C Agent for animal growth promotion |
| 03/31/1994 | WO1994007143A1 Diagnosis of autosomal muscular dystrophy |
| 03/31/1994 | WO1994006938A1 Methods for preventing multidrug resistance in cancer cells |
| 03/31/1994 | WO1994006929A1 Small cell lung carcinoma specific antibody and antigen |
| 03/31/1994 | WO1994006921A1 Recombinant retroviral vector against felv and/or fiv |
| 03/31/1994 | WO1994006916A1 Gene transcription and ionizing radiation: methods and compositions |
| 03/31/1994 | WO1994006913A2 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines |
| 03/31/1994 | WO1994006910A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 03/31/1994 | WO1994006909A2 A method of preventing tumor metastasis |
| 03/31/1994 | WO1994006904A1 Novel infectious bursal disease virus |
| 03/31/1994 | WO1994006830A1 Fibrinogen binding protein |
| 03/31/1994 | WO1994006829A1 Basophil granule proteins |
| 03/31/1994 | WO1994006828A1 Peptides tolerizing t-cells and compositions thereof |
| 03/31/1994 | WO1994006827A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 03/31/1994 | WO1994006825A1 Ureido-acetamide derivatives, preparation thereof and drugs containing same |
| 03/31/1994 | WO1994006824A1 Optically active ureido-acetamide derivative, its preparation and drugs containing same |
| 03/31/1994 | WO1994006823A1 Reagents and methods for treating rheumatoid arthritis |
| 03/31/1994 | WO1994006822A1 Method of isolating biomolecules by ion exchange |
| 03/31/1994 | WO1994006820A1 Leukinferon preparation |
| 03/31/1994 | WO1994006818A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | WO1994006814A1 Ikaros: a t cell pathway regulatory gene |
| 03/31/1994 | WO1994006813A1 Major histocompatibility complex molecules and modifications thereof |
| 03/31/1994 | WO1994006792A1 Optically active hydroquinine (amino-3 phenyl)-1 ethanesulfonate, preparation and use thereof |
| 03/31/1994 | WO1994006760A1 Optically active alkylammonium (amino-3 phenyl)-1 ethanesulfonate derivatives, preparation and use thereof |
| 03/31/1994 | WO1994006755A1 Alcohol derivative having renin-inhibiting activity and use thereof |
| 03/31/1994 | WO1994006476A1 Method of treating tnf-dependent inflammation using tumor necrosis factor antagonists |
| 03/31/1994 | WO1994006475A1 Attenuated, live vaccine for delaware strain ibdv |
| 03/31/1994 | WO1994006473A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | WO1994006470A1 Immunoreactive peptides from epstein-barr virus |
| 03/31/1994 | WO1994006469A1 Hiv fusion polypeptide |
| 03/31/1994 | WO1994006462A1 Use of lectins for treatment of skin diseases |
| 03/31/1994 | WO1994006461A1 Method of prophylaxis of acute renal failure |
| 03/31/1994 | WO1994006459A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 03/31/1994 | WO1994006458A1 Highly concentrated mcsf compositions |
| 03/31/1994 | WO1994006457A1 Pharmaceutical formulations of interleukin-1 inhibitors |
| 03/31/1994 | WO1994006456A1 Protection against liver damage by hgf |
| 03/31/1994 | WO1994006455A1 Method of producing analgesia using neurotrophins |
| 03/31/1994 | WO1994006454A2 Inhibitiion of retrovirus infection |
| 03/31/1994 | WO1994006453A1 Bradykinin antagonists containing aliphatic amino acids in the 5-position |
| 03/31/1994 | WO1994006452A1 Sustained-release protein formulations |
| 03/31/1994 | WO1994006451A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | WO1994006450A1 Brain-enhanced delivery of neuroactive peptides by sequential metabolism |
| 03/31/1994 | WO1994006449A2 Morphogen-induced liver regeneration |
| 03/31/1994 | WO1994006448A1 Human neutralizing monoclonal antibodies to respiratory syncytial virus |
| 03/31/1994 | WO1994006447A2 60a protein-induced morphogenesis |
| 03/31/1994 | WO1994006445A1 Method of administering igf-1, igf-2, and analogs thereof to birds |
| 03/31/1994 | WO1994006444A1 Germicidal detergent-iodine compositions having reduced detergent content |
| 03/31/1994 | WO1994006442A1 Sulfated ligands for l-selectins and use of chlorates and or sulfatases for the treatment of inflammation |
| 03/31/1994 | WO1994006428A1 Method of preventing nmda receptor complex-mediated neuronal damage |
| 03/31/1994 | WO1994006420A2 Morphogen treatment of gastrointestinal ulcers |
| 03/31/1994 | WO1994006399A1 Morphogen-induced periodontal tissue regeneration |
| 03/31/1994 | WO1994006306A1 A process for producing beta-casein enriched products |
| 03/31/1994 | WO1994004691A3 Dimer and multimer forms of single chain polypeptides |
| 03/31/1994 | WO1994003611A3 Ptp-d subfamily of protein tyrosine phosphatases |
| 03/31/1994 | WO1994002611A3 Recombinant human erythropoietin with altered biological activity |
| 03/31/1994 | WO1994001547A3 A method for generation of antibodies to cell surface molecules |
| 03/31/1994 | WO1994000489A3 Radioactively-labeled somatostantin-derived peptides for imaging and therapeutic uses |
| 03/31/1994 | WO1993023549A3 Nucleic acid corresponding to a gene of chromosome 22 involved in recurrent chromosomal translocations associated with the development of cancerous tumors |
| 03/31/1994 | DE4244735A1 Medical use of C1 activator - to combat complications of therapy with cytokines, mediators or growth factors |
| 03/31/1994 | DE4229880A1 Medicaments contg. oxytocin, vasopressin and/or endorphins - for treating sex crime, bed-wetting, autism, homosexulaity and bulimia |
| 03/31/1994 | CA2145412A1 Interferon regulatory factors 1 and 2 in the diagnosis of tumorigenicity |
| 03/31/1994 | CA2145179A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof |
| 03/31/1994 | CA2144882A1 Synthetic peptide vaccine for chlamydia trachomatis |
| 03/31/1994 | CA2144856A1 A method of preventing tumor metastasis |
| 03/31/1994 | CA2144848A1 Gene therapy by retroviral vector with tumor suppressive gene |
| 03/31/1994 | CA2144773A1 Brain enhanced delivery of neuroactive peptides by sequential metabolism |
| 03/31/1994 | CA2144750A1 Tumor-specific antibodies and antigen |
| 03/31/1994 | CA2144648A1 Restoration of immunocompetency to t helper cells in hiv infected patients |
| 03/31/1994 | CA2144539A1 Method of producing analgesia using neurotrophins |
| 03/31/1994 | CA2144515A1 Morphogen treatment of gastrointestinal ulcers |
| 03/31/1994 | CA2144409A1 Peptides tolerizing t-cells and compositions thereof |
| 03/31/1994 | CA2144159A1 Optically active alkylammonium 1-(3-aminophenyl)ethanesulfonate; preparation thereof and its use |
| 03/31/1994 | CA2144158A1 Optically active hydroquinine 1-(3-aminophenyl)ethanesulfonate; preparation thereof and its use |
| 03/31/1994 | CA2144067A1 Synthesis of n-substituted oligomers |
| 03/31/1994 | CA2144050A1 Use of lectins for treatment of skin diseases |
| 03/31/1994 | CA2144044A1 Reagents and methods for treating rheumatoid arthritis |
| 03/31/1994 | CA2144039A1 Ureido-acetamides derivatives, preparation thereof and drugs containing same |
| 03/31/1994 | CA2142325A1 Recombinant retroviral vector against felv and/or fiv |
| 03/31/1994 | CA2142203A1 Basophil granule proteins |
| 03/31/1994 | CA2124210A1 Fibrinogen binding protein |
| 03/31/1994 | CA2123584A1 Attenuated, live vaccine for delaware strain ibdv |